https://www.selleckchem.com/pr....oducts/pimicotinib.h
Thrombolysis with tissue plasminogen activator is a mainstream treatment for ischemic stroke. Known risks with thrombolysis include intracerebral hemorrhage and bleeding elsewhere in the body. There are no specific recommendations for the timing of commencing mobility rehabilitation after thrombolysis. Research evidence for early mobilization (within 24hours) after thrombolysis is sparse and little is known about physiotherapy practice in the UK. This exploratory study aimed to investigate the experiences, including clinical decisio
Like
Comment
Share
